Jae-Lyun Lee

Jae-Lyun Lee

UNVERIFIED PROFILE

Are you Jae-Lyun Lee?   Register this Author

Register author
Jae-Lyun Lee

Jae-Lyun Lee

Publications by authors named "Jae-Lyun Lee"

Are you Jae-Lyun Lee?   Register this Author

100Publications

3443Reads

37Profile Views

Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients.

Cancer Res Treat 2019 Oct 25;51(4):1549-1556. Epub 2019 Mar 25.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2019.086DOI Listing
October 2019

Adjuvant Treatments for Advanced Stage, Non-metastatic Upper Tract Urothelial Carcinoma: A Multicenter Study.

Int J Radiat Oncol Biol Phys 2019 Jul 26;104(4):819-827. Epub 2019 Mar 26.

Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2019.03.027DOI Listing
July 2019

3'-Deoxy-3'-F-Fluorothymidine and F-Fluorodeoxyglucose positron emission tomography for the early prediction of response to Regorafenib in patients with metastatic colorectal cancer refractory to all standard therapies.

Eur J Nucl Med Mol Imaging 2019 Jul 30;46(8):1713-1722. Epub 2019 Apr 30.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00259-019-04330-7DOI Listing
July 2019

Random Allocated Study of Wrapping Oblate for Prevention of Everolimus-associated Stomatitis in Patients With Metastatic Renal Cell Carcinoma.

Anticancer Res 2019 Jul;39(7):3937-3944

Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.13546DOI Listing
July 2019

Induction Chemotherapy Followed by Surgery Versus Upfront Radical Cystectomy in Patients With Clinically Node-positive Muscle-invasive Bladder Cancer.

Clin Genitourin Cancer 2019 Jun 9;17(3):e420-e428. Epub 2019 Jan 9.

Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2019.01.001DOI Listing
June 2019

Adjuvant chemotherapy versus observation after radical cystectomy in patients with node-positive bladder cancer.

Sci Rep 2019 Jun 5;9(1):8305. Epub 2019 Jun 5.

Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-44504-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549178PMC
June 2019

A multicenter, prospective phase II trial of gemcitabine plus axitinib in patients with renal cell carcinoma with a predominant sarcomatoid component.

Invest New Drugs 2019 Jun 24. Epub 2019 Jun 24.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-019-00817-0DOI Listing
June 2019

Epithelial-mesenchymal transition as a mechanism of resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma.

Lab Invest 2019 May 25;99(5):659-670. Epub 2019 Jan 25.

Department of Pathology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41374-019-0188-yDOI Listing
May 2019

Development of Response Classifier for Vascular Endothelial Growth Factor Receptor (VEGFR)-Tyrosine Kinase Inhibitor (TKI) in Metastatic Renal Cell Carcinoma.

Pathol Oncol Res 2019 Jan 29;25(1):51-58. Epub 2017 Sep 29.

Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12253-017-0323-2DOI Listing
January 2019

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05).

Cancer Res Treat 2018 Oct 2;50(4):1252-1259. Epub 2018 Jan 2.

Division of Oncology/Hematology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2017.438DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6192917PMC
October 2018

A Multicenter Phase II Trial of Axitinib in Patients With Recurrent or Metastatic Non-clear-cell Renal Cell Carcinoma Who Had Failed Prior Treatment With Temsirolimus.

Clin Genitourin Cancer 2018 10 23;16(5):e997-e1002. Epub 2018 May 23.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clgc.2018.05.011DOI Listing
October 2018

Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer.

BMC Med Genomics 2018 Oct 3;11(1):88. Epub 2018 Oct 3.

Departments of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12920-018-0406-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171176PMC
October 2018

Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer.

J Clin Oncol 2018 06 28;36(16):1579-1587. Epub 2018 Mar 28.

David J. Vaughn, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Joaquim Bellmunt and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA; Yves Fradet, CHU de Québec-Université Laval, Quebec City, Quebec, Canada; Jae Lyun Lee, Asan Medical Center and University of Ulsan College of Medicine, Seoul, Republic of Korea; Lawrence Fong, University of California, San Francisco, San Francisco; David I. Quinn, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA; Nicholas J. Vogelzang, Comprehensive Cancer Centers of Nevada, Las Vegas, NV; Miguel A. Climent, Fundación Instituto Valenciano de Oncología, Valencia, Spain; Daniel P. Petrylak, Smilow Cancer Hospital, Yale University, New Haven, CT; Andrea Necchi, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan; Cora N. Sternberg, San Camillo and Forlanini Hospitals, Rome, Italy; Winald Gerritsen, Radboud University Medical Center, Nijmegen; Ronald de Wit, Erasmus University Medical Center Cancer Institute, Rotterdam, the Netherlands; Howard Gurney, Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia; Stephane Culine, Hôpital Saint-Louis, Paris, France; Yabing Mai, Haojie Li, and Rodolfo F. Perini, Merk & Co., Inc., Kenilworth, NJ; and Dean F. Bajorin, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2017.76.9562
Publisher Site
http://dx.doi.org/10.1200/JCO.2017.76.9562DOI Listing
June 2018

Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study.

Cancer Res Treat 2018 Apr 22;50(2):488-494. Epub 2017 May 22.

Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://www.e-crt.org/journal/view.php?doi=10.4143/crt.2016.5
Publisher Site
http://dx.doi.org/10.4143/crt.2016.584DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5912146PMC
April 2018

Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial.

Trials 2018 Apr 2;19(1):212. Epub 2018 Apr 2.

Department of Radiation Oncology, Asan Medical Center, University of Ulsan, College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13063-018-2574-yDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879839PMC
April 2018

Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial.

J Clin Oncol 2018 03 29;36(8):757-764. Epub 2018 Jan 29.

David Cella, Northwestern University Feinberg School of Medicine, Chicago, IL; Bernard Escudier, Institut Gustave Roussy, Villejuif; Florence Marteau, Ipsen Pharma, Boulogne-Billancourt; Paul Williams, Mapi Group, Lyon, France; Nizar M. Tannir, University of Texas MD Anderson Cancer Center Hospital, Houston; Hans J. Hammers, University of Texas Southwestern Medical Center; Thomas E. Hutson, Texas Oncology-Baylor Sammons Cancer Center, Dallas, TX; Thomas Powles, Queen Mary University of London, London, United Kingdom; Frede Donskov, Aarhus University Hospital, Aarhus, Denmark; Katriina Peltola, Helsinki University Hospital Cancer Center, Helsinki, Finland; Manuela Schmidinger, Medical University of Vienna, Vienna, Austria; Daniel Y.C. Heng, University of Calgary, Calgary, Alberta, Canada; Paul N. Mainwaring, Icon Cancer Care, Brisbane, Queensland, Australia; Jae Lyun Lee, University of Ulsan College of Medicine, Seoul, South Korea; Bruce J. Roth, Washington University in St Louis, St Louis, MO; John Baer, Milan Mangeshkar, and Christian Scheffold, Exelixis, South San Francisco; Sumanta Pal, City of Hope National Medical Center, Duarte, CA; Robert J. Motzer, Memorial Sloan Kettering Cancer Center, New York, NY; and Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.2170DOI Listing
March 2018

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.

J Clin Oncol 2017 Dec 13;35(35):3916-3923. Epub 2017 Sep 13.

Robert J. Motzer and Paul Russo, Memorial Sloan Kettering Cancer Center, New York, NY; Naomi B. Haas, University of Pennsylvania, Philadelphia, PA; Frede Donskov, Aarhus University Hospital, Aarhus, Denmark; Marine Gross-Goupil, Bordeaux University Hospital, Bordeaux, France; Sergei Varlamov, Altai Regional Cancer Center, Barnaul; Evgeny Kopyltsov, State Institution of Healthcare Regional Clinical Oncology Dispensary, Omsk, Russia; Jae Lyun Lee, University of Ulsan College of Medicine; Ho Yeong Lim, Sungkyunkwan University, Seoul, Republic of Korea; Bohuslav Melichar, Palacky University Medical School and Teaching Hospital, Olomouc; Milada Zemanova, Charles University and General University Hospital, Prague, Czech Republic; Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Toni K. Choueiri, Dana-Farber Cancer Institute, Boston, MA; Lori A. Wood, Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia; M. Neil Reaume, Ottawa Hospital Cancer Centre, Ottawa, Ontario, Canada; Arnulf Stenzl, University Hospital Tübingen, Tübingen; Christian Doehn, University of Lübeck Medical School and Urologikum Lübeck, Lübeck, Germany; Simon Chowdhury, Guy's and St Thomas' National Health Service Foundation/St Thomas' Hospital, London; Ray McDermott, Tallaght University Hospital and Cancer Trials Ireland, Dublin; Agnieszka Michael, University of Surrey, Guildford, United Kingdom; Weichao Bao, Marlene J. Carrasco-Alfonso, and Maurizio Voi, Novartis Oncology, East Hanover, NJ; Paola Aimone, Novartis Pharma AG, Basel, Switzerland; and Cora N. Sternberg, San Camillo Forlanini Hospital, Rome, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.73.5324DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6018511PMC
December 2017

Prognostic Value of Treatment Setting in Patients With Cancer Having Pulmonary Embolism: Comparison With the Pulmonary Embolism Severity Index.

Clin Appl Thromb Hemost 2017 Sep 11;23(6):615-621. Epub 2016 Jan 11.

2 Department of Oncology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1076029615625826DOI Listing
September 2017

Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis.

Oncotarget 2017 Sep 25;8(40):68996-69004. Epub 2017 Mar 25.

Department of Radiation Oncology, Asan Medical Center, University of Ulsan, College of Medicine, Songpa-Gu, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.16576DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620314PMC
September 2017

Efficacy of metronomic oral cyclophosphamide with low dose dexamethasone and celecoxib in metastatic castration-resistant prostate cancer.

Asia Pac J Clin Oncol 2017 Jun 12;13(3):204-211. Epub 2016 Aug 12.

Department of Medicine, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajco.12583DOI Listing
June 2017

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.

N Engl J Med 2017 03 17;376(11):1015-1026. Epub 2017 Feb 17.

From Dana-Farber Cancer Institute, Boston (J.B., T.K.C.); Parc de Salut Mar, Hospital del Mar Medical Research Institute, Barcelona (J.B.), and Fundación Instituto Valenciano de Oncología, Valencia (M.A.C.) - both in Spain; Erasmus MC Cancer Institute, Rotterdam (R.W.), and Radboud University Medical Center, Nijmegen (W.G.) - both in the Netherlands; Abramson Cancer Center, University of Pennsylvania, Philadelphia (D.J.V.); Centre Hospitalier Universitaire de Québec-Université Laval, Quebec, QC, Canada (Y.F.); Asan Medical Center and University of Ulsan College of Medicine, Seoul, South Korea (J.-L.L.); the University of California, San Francisco, San Francisco (L.F.); Comprehensive Cancer Centers of Nevada, Las Vegas (N.J.V.); Smilow Cancer Hospital, Yale University, New Haven, CT (D.P.P.); Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (A.N.); Westmead Hospital and Macquarie University, Sydney (H.G.); the University of Southern California Norris Comprehensive Cancer Center and Hospital, Los Angeles (D.I.Q.); Hôpital Saint-Louis, Paris (S.C.); San Camillo and Forlanini Hospitals, Rome (C.N.S.); Merck, Kenilworth, NJ (Y.M., C.H.P., R.F.P.); and Memorial Sloan Kettering Cancer Center, New York (D.F.B.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1613683DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5635424PMC
March 2017

Clinical outcome of high-dose bolus intravenous interleukin-2 with a modified administration schedule for Asian patients with metastatic renal cell carcinoma.

Cancer Chemother Pharmacol 2017 Jan 23;79(1):173-180. Epub 2016 Dec 23.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-016-3222-4DOI Listing
January 2017

Donor-Derived Natural Killer Cell Infusion after Human Leukocyte Antigen-Haploidentical Hematopoietic Cell Transplantation in Patients with Refractory Acute Leukemia.

Biol Blood Marrow Transplant 2016 11 12;22(11):2065-2076. Epub 2016 Aug 12.

Hematology and Oncology Sections, Department of Internal Medicine, College of Medicine, Asan Medical Center, University of Ulsan, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2016.08.008DOI Listing
November 2016

Impact of metastasectomy on prognosis in patients treated with targeted therapy for metastatic renal cell carcinoma.

J Cancer Res Clin Oncol 2016 Nov 23;142(11):2331-8. Epub 2016 Aug 23.

Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 05505, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-016-2217-1DOI Listing
November 2016

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

J Clin Oncol 2016 Oct;34(30):3655-3663

Laurence Albiges, Wanling Xie, Rana R. McKay, Andre P. Fay, Guillermo de Velasco, Sabina Signoretti, and Toni K. Choueiri, Dana-Farber Cancer Institute; Wanling Xie, Rana R. McKay, Mark A. Preston, Eunyoung Cho, Sabina Signoretti, and Toni K. Choueiri, Brigham and Women's Hospital; Laurence Albiges, Wanling Xie, Rana R. McKay, Andre P. Fay, Guillermo de Velasco, Eunyoung Cho, David F. McDermott, Sabina Signoretti, and Toni K. Choueiri, Harvard Medical School; Mark A. Preston and Kathryn M. Wilson, Harvard School of Public Health; David F. McDermott, Beth Israel Deaconess Medical Center, Boston, MA; Laurence Albiges, Gustave Roussy, Université Paris-Saclay, Villejuif, France; A. Ari Hakimi, Emily C. Zabor, Anders J. Skanderup, and Helena Furberg, Memorial Sloan Kettering Cancer Center, New York; Ronit Simantov and Xun Lin, Pfizer Oncology, New York, NY; Jae-Lyun Lee, University of Ulsan College of Medicine, Asan; Sun-Young Rha, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea; Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Sandy Srinivas, Stanford Cancer Institute, Stanford; Sumanta K. Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Georg A. Bjarnason, Sunnybrook Odette Cancer Center, Toronto; Scott Ernst, London Health Sciences Center, London, Ontario; Lori A. Wood, Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Daniel Y.C. Heng, Tom Baker Cancer Center; University of Calgary, Calgary, Alberta, Canada; Ulka N. Vaishamayan, Karmanos Cancer Center, Detroit, MI; Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Takeshi Yuasa, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; Aristotelis Bamias, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; and Eunyoung Cho, The Warren Alpert Medical School of Brown University; Brown University School of Public Health, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065111PMC
October 2016

Pazopanib versus sunitinib for the treatment of metastatic renal cell carcinoma patients with poor-risk features.

Cancer Chemother Pharmacol 2016 Aug 21;78(2):325-32. Epub 2016 Jun 21.

Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-016-3093-8
Publisher Site
http://dx.doi.org/10.1007/s00280-016-3093-8DOI Listing
August 2016

A Korean multi-center, real-world, retrospective study of first-line pazopanib in unselected patients with metastatic renal clear-cell carcinoma.

BMC Urol 2016 Aug 2;16(1):46. Epub 2016 Aug 2.

Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12894-016-0163-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4970295PMC
August 2016

Clinicopathological Features Associated With the Prognosis of Patients With Adrenal Cortical Carcinoma: Usefulness of the Ki-67 Index.

Medicine (Baltimore) 2016 May;95(21):e3736

From the Departments of Internal Medicine (YMC, HK, MJJ, TYK, WBK, YKS, JLL, WGK), Surgery (T-YS, SJH), and Pathology (DES), Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MD.0000000000003736DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902359PMC
May 2016

Prognostic tissue biomarker exploration for patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor receptor tyrosine kinase inhibitors.

Tumour Biol 2016 Apr 3;37(4):4919-27. Epub 2015 Nov 3.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13277-015-4339-5DOI Listing
April 2016

Contrast-induced nephropathy in patients with active cancer undergoing contrast-enhanced computed tomography.

Support Care Cancer 2016 Mar 4;24(3):1011-7. Epub 2015 Aug 4.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-015-2875-6
Publisher Site
http://dx.doi.org/10.1007/s00520-015-2875-6DOI Listing
March 2016

A new prognostic model for chemotherapy-induced febrile neutropenia.

Int J Clin Oncol 2016 Feb 7;21(1):46-52. Epub 2015 Jun 7.

Division of Biostatistics, Center for Medical Research and Information, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10147-015-0853-0DOI Listing
February 2016

Long-term outcomes of tyrosine kinase inhibitor discontinuation in patients with metastatic renal cell carcinoma.

Cancer Chemother Pharmacol 2016 Feb 21;77(2):339-47. Epub 2015 Dec 21.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2942-1DOI Listing
February 2016

Histological and immunohistochemical markers for progression prediction in transurethrally resected high-grade non-muscle invasive bladder cancer.

Int J Clin Exp Pathol 2015 1;8(1):743-50. Epub 2015 Jan 1.

Department of Pathology, Hallym University Dongtan Sacred Heart Hospital Republic of Korea.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348879PMC
December 2015

Defective Mismatch Repair Status was not Associated with DFS and OS in Stage II Colon Cancer Treated with Adjuvant Chemotherapy.

Ann Surg Oncol 2015 Dec 14;22 Suppl 3:S630-7. Epub 2015 Aug 14.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-015-4807-6DOI Listing
December 2015

Cabozantinib versus Everolimus in Advanced Renal-Cell Carcinoma.

N Engl J Med 2015 Nov 25;373(19):1814-23. Epub 2015 Sep 25.

From the Dana-Farber Cancer Institute, Boston (T.K.C., P.W.K.); Institut Gustave Roussy, Villejuif, France (B.E.); Barts Cancer Institute, Cancer Research UK Experimental Cancer Medicine Centre, Queen Mary University of London, Royal Free NHS Trust, London (T.P.); Icon Cancer Care, South Brisbane, QLD, Australia (P.N.M.); Cleveland Clinic, Cleveland (B.I.R.); Aarhus University Hospital, Aarhus, Denmark (F.D.); Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore (H.H.); Texas Oncology-Charles A. Sammons Cancer Center, Baylor University, Dallas (T.E.H.); University of Ulsan College of Medicine (J.-L.L.) and Seoul National University Hospital (B.K.) - both in Seoul, South Korea; Helsinki University Central Hospital Cancer Center, Helsinki (K.P.); Washington University in St. Louis, St. Louis (B.J.R.); Sunnybrook Odette Cancer Centre, Toronto (G.A.B.), and Tom Baker Cancer Centre, Calgary, AB (D.Y.C.H.) - both in Canada; National Institute of Oncology, Budapest, Hungary (L.G.); Hospital de la Santa Creu i Sant Pau, Barcelona (P.M.); Medical University of Vienna, Vienna (M.S.); Exelixis, South San Francisco, CA (A.B-H., C.H., C.S., G.M.S.); University of Texas M.D. Anderson Cancer Center, Houston (N.M.T.); and the Memorial Sloan Kettering Cancer Center, New York (R.J.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1510016DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024539PMC
November 2015

First-in-human study of the toxicity, pharmacokinetics, and pharmacodynamics of CG200745, a pan-HDAC inhibitor, in patients with refractory solid malignancies.

Invest New Drugs 2015 Oct 17;33(5):1048-57. Epub 2015 Jun 17.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-015-0262-2DOI Listing
October 2015

Impact of time to antibiotics on outcomes of chemotherapy-induced febrile neutropenia.

Support Care Cancer 2015 Sep 10;23(9):2799-804. Epub 2015 Feb 10.

Department of Emergency Medicine, Cancer Emergency Room, Asan Medical Center, University of Ulsan College of Medicine, 388-1, Pungnap-dong, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-015-2645-5
Publisher Site
http://dx.doi.org/10.1007/s00520-015-2645-5DOI Listing
September 2015

Pulmonary Metastasectomy Could Prolong Overall Survival in Select Cases of Metastatic Urinary Tract Cancer.

Clin Genitourin Cancer 2015 Aug 2;13(4):e297-e304. Epub 2015 May 2.

Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15587673150009
Publisher Site
http://dx.doi.org/10.1016/j.clgc.2015.04.013DOI Listing
August 2015

Gemcitabine plus split-dose cisplatin could be a promising alternative to gemcitabine plus carboplatin for cisplatin-unfit patients with advanced urothelial carcinoma.

Cancer Chemother Pharmacol 2015 Jul 23;76(1):141-53. Epub 2015 May 23.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2774-zDOI Listing
July 2015

Vascular endothelial growth factor receptor tyrosine kinase inhibitor (VEGFR-TKI) rechallenge for patients with metastatic renal cell carcinoma after treatment failure using both VEGFR-TKI and mTOR inhibitor.

Cancer Chemother Pharmacol 2015 May 17;75(5):1025-35. Epub 2015 Mar 17.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2725-8DOI Listing
May 2015

Improving trends in survival of patients who receive chemotherapy for metastatic or recurrent gastric cancer: 12 years of experience at a single institution.

Gastric Cancer 2015 Apr 16;18(2):346-53. Epub 2014 May 16.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10120-014-0385-8DOI Listing
April 2015

TFAP2E methylation status and prognosis of patients with radically resected colorectal cancer.

Oncology 2015 23;88(2):122-32. Epub 2014 Oct 23.

Department of Oncology, Asan Institute for Life Science, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000362820DOI Listing
April 2015

Intravenous 3-weekly paclitaxel and metronomic oral cyclophosphamide in patients with advanced urothelial cancer previously treated with gemcitabine and platinum.

Cancer Chemother Pharmacol 2015 Feb 27;75(2):247-54. Epub 2014 Nov 27.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-014-2640-4DOI Listing
February 2015

Predicting the efficacy of an oral paclitaxel formulation (DHP107) through modeling and simulation.

Clin Ther 2015 Feb 8;37(2):402-17. Epub 2015 Jan 8.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinthera.2014.12.009DOI Listing
February 2015

Predictive role of tissue-based molecular markers in patients treated with sunitinib for metastatic renal cell carcinoma.

World J Urol 2015 Jan 8;33(1):111-8. Epub 2014 Apr 8.

Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-Ro 43-Gil, Songpa-Gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-014-1295-4DOI Listing
January 2015

Effectiveness and safety of cabazitaxel plus prednisolone chemotherapy for metastatic castration-resistant prostatic carcinoma: data on Korean patients obtained by the cabazitaxel compassionate-use program.

Cancer Chemother Pharmacol 2014 Nov 6;74(5):1005-13. Epub 2014 Sep 6.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil Songpa-gu, Seoul, 138-736, Korea,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00280-014-2579-5
Publisher Site
http://dx.doi.org/10.1007/s00280-014-2579-5DOI Listing
November 2014

The Choi response criteria for inferior vena cava tumor thrombus in renal cell carcinoma treated with targeted therapy.

J Cancer Res Clin Oncol 2014 Oct 20;140(10):1751-8. Epub 2014 May 20.

Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://link.springer.com/content/pdf/10.1007/s00432-014-1703
Web Search
http://link.springer.com/10.1007/s00432-014-1703-6
Publisher Site
http://dx.doi.org/10.1007/s00432-014-1703-6DOI Listing
October 2014

Changes in the diffusion capacity for carbon monoxide and the development of non-infectious pneumonitis in patients with metastatic renal cell carcinoma treated with everolimus.

Anticancer Res 2014 Oct;34(10):5723-8

Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
October 2014

Impact of surgery on the prognosis of metastatic renal cell carcinoma with IVC thrombus received TKI therapy.

J Surg Oncol 2014 Aug 3;110(2):145-50. Epub 2014 Apr 3.

Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jso.23612DOI Listing
August 2014

Active surveillance for metastatic or recurrent renal cell carcinoma.

J Cancer Res Clin Oncol 2014 Aug 22;140(8):1421-8. Epub 2014 Apr 22.

Department of Oncology, Asan Medical Centre, University of Ulsan College of Medicine, 88 Olympic-Ro 43-Gil, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-014-1680-9DOI Listing
August 2014

Sarcomatoid features, necrosis, and grade are prognostic factors in metastatic clear cell renal cell carcinoma with vascular endothelial growth factor-targeted therapy.

Hum Pathol 2014 Jul 6;45(7):1437-44. Epub 2014 Mar 6.

Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, Republic of Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2014.02.019DOI Listing
July 2014

NPS-1034, a novel MET inhibitor, inhibits the activated MET receptor and its constitutively active mutants.

Invest New Drugs 2014 Jun 31;32(3):389-99. Epub 2013 Oct 31.

Institute for Innovative Cancer Research, University of Ulsan College of Medicine, Asan Medical Center, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-013-0039-4DOI Listing
June 2014

Randomised phase II trial of photodynamic therapy plus oral fluoropyrimidine, S-1, versus photodynamic therapy alone for unresectable hilar cholangiocarcinoma.

Eur J Cancer 2014 May 30;50(7):1259-68. Epub 2014 Jan 30.

Department of Clinical Epidemiology and Biostatistics, University of Ulsan College of Medicine, Asan Medical Centre, Seoul, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2014.01.008DOI Listing
May 2014

Donor-derived natural killer cells infused after human leukocyte antigen-haploidentical hematopoietic cell transplantation: a dose-escalation study.

Biol Blood Marrow Transplant 2014 May 11;20(5):696-704. Epub 2014 Feb 11.

Hematology and Oncology Sections, Department of Internal Medicine, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbmt.2014.01.031DOI Listing
May 2014

NVP-BEZ235, a dual PI3K/mTOR inhibitor, induces cell death through alternate routes in prostate cancer cells depending on the PTEN genotype.

Apoptosis 2014 May;19(5):895-904

Innovative Cancer Research, Asan Institute for Life Science, University of Ulsan College of Medicine, Asan Medical Center, 86 Asanbyeongwon-gil, Songpa-gu, Seoul, 138-736, Republic of Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10495-014-0973-4DOI Listing
May 2014

A prospective multicenter phase II study of sunitinib in patients with advanced aggressive fibromatosis.

Invest New Drugs 2014 Apr 16;32(2):369-76. Epub 2014 Jan 16.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-013-0059-0DOI Listing
April 2014

Enhanced efficacy of postoperative adjuvant chemotherapy in advanced gastric cancer: results from a phase 3 randomized trial (AMC0101).

Cancer Chemother Pharmacol 2014 Jan 27;73(1):139-49. Epub 2013 Oct 27.

Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul, 138-736, Korea,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-013-2332-5DOI Listing
January 2014

Adjuvant radiotherapy for stage III/IV urothelial carcinoma of the upper tract.

Anticancer Res 2014 Jan;34(1):333-8

M.D., Department of Radiation Oncology, Asan Medical Center, University of Ulsan, College of Medicine, 88, Olympic-ro 43-gil, Songpa-gu, Seoul 138-736, Republic of Korea.

View Article

Download full-text PDF

Source
January 2014

Sunitinib treatment for metastatic renal cell carcinoma in patients with von hippel-lindau disease.

Cancer Res Treat 2013 Dec 31;45(4):349-53. Epub 2013 Dec 31.

Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4143/crt.2013.45.4.349DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893333PMC
December 2013